Elderly Nutrition Market

By Nutrition Type;

Minerals, Multi-Vitamins, Iron, Proteins, Fibers, Lipids, Antioxidants, and Others

By Route of Administration;

Oral, Parenteral, Enteral, and Metabolism & GIT Management

By Application;

Diabetes, Renal Failures, Obesity, Sarcopenia, Cancer, and Others

By Distribution Channel;

Hospitals & Clinics, Retail Pharmacies, Convenience Store, Online, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn849048440 Published Date: August, 2025

Introduction

Global Elderly Nutrition Market (USD Million), 2021 - 2031

In the year 2024, the Global Elderly Nutrition Market was valued at USD 16,403.36 million. The size of this market is expected to increase to USD 22,173.60 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.4%.


Elderly Nutrition Market

*Market size in USD million

CAGR 4.4 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.4 %
Market Size (2024)USD 16,403.36 Million
Market Size (2031)USD 22,173.60 Million
Market ConcentrationHigh
Report Pages331
16,403.36
2024
22,173.60
2031

Major Players

  • Otsuka Pharmaceuticals Co., Ltd
  • Baxter International Inc
  • Allergan
  • Danone
  • Abbott Laboratories
  • Pfizer, Inc
  • Mead Johnson & Company
  • Sanofi

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Elderly Nutrition Market

Fragmented - Highly competitive market without dominant players


The global elderly nutrition market is a burgeoning sector driven by the increasing aging population worldwide. As demographics shift towards older age groups, there's a growing awareness of the unique nutritional needs of seniors. This market encompasses a wide range of products and services tailored to address the specific dietary requirements and health concerns of the elderly population. From supplements fortified with essential vitamins and minerals to specialized meal plans designed to support healthy aging, the global elderly nutrition market caters to the diverse needs of seniors looking to maintain their well-being and vitality.

One of the key driving factors behind the expansion of the elderly nutrition market is the rising prevalence of age-related health conditions such as osteoporosis, sarcopenia, and cognitive decline. As individuals age, their nutritional needs change, and there's a greater emphasis on consuming nutrients that support bone health, muscle mass retention, and cognitive function. This has led to a surge in demand for functional foods and dietary supplements specifically formulated to address these concerns, driving innovation and investment in the elderly nutrition market.

Changing lifestyles and dietary habits have also contributed to the growth of the global elderly nutrition market. Urbanization, busy schedules, and the prevalence of processed foods have led to dietary imbalances and deficiencies, particularly among older adults. As a result, there's a growing recognition of the importance of nutrition in promoting healthy aging and preventing age-related diseases. This awareness has fueled the adoption of nutritional interventions and personalized dietary plans, driving the expansion of the elderly nutrition market worldwide.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Nutrition Type
    2. Market Snapshot, By Route of Administration
    3. Market Snapshot, By Application
    4. Market Snapshot, By Distribution Channel
    5. Market Snapshot, By Region
  4. Elderly Nutrition Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging Population
        2. Health Consciousness
        3. Chronic Diseases
        4. Nutritional Deficiencies
      2. Restraints
        1. Economic Constraints
        2. Affordability Issues
        3. Limited Access to Healthcare
        4. Cultural Dietary Preferences
      3. Opportunities
        1. Market Expansion
        2. Aging Population Growth
        3. Rising Healthcare Expenditure
        4. Technological Advancements
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Elderly Nutrition Market, By Nutrition Type, 2021 - 2031 (USD Million)
      1. Minerals
      2. Multi-Vitamins
      3. Iron
      4. Proteins
      5. Fibers
      6. Lipids
      7. Antioxidants
      8. Others
    2. Elderly Nutrition Market, By Route of Administration, 2021 - 2031 (USD Million)

      1. Oral

      2. Parenteral

      3. Enteral

      4. Metabolism & GIT Management

    3. Elderly Nutrition Market, By Application, 2021 - 2031 (USD Million)
      1. Diabetes
      2. Renal Failures
      3. Obesity
      4. Sarcopenia
      5. Cancer
      6. Others
    4. Elderly Nutrition Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Hospitals & Clinics
      2. Retail Pharmacies
      3. Convenience Store
      4. Online
      5. Others
    5. Elderly Nutrition Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Otsuka Pharmaceuticals Co., Ltd
      2. Baxter International Inc
      3. Allergan
      4. Danone
      5. Abbott Laboratories
      6. Pfizer, Inc
      7. Mead Johnson & Company
      8. Sanofi
  7. Analyst Views
  8. Future Outlook of the Market